118 related articles for article (PubMed ID: 23234235)
1. Noncovalent complexation of amphotericin-B with Poly(α-glutamic acid).
Mohamed-Ahmed AH; Les KA; Seifert K; Croft SL; Brocchini S
Mol Pharm; 2013 Mar; 10(3):940-50. PubMed ID: 23234235
[TBL] [Abstract][Full Text] [Related]
2. Antileishmanial activity, uptake, and biodistribution of an amphotericin B and poly(α-Glutamic Acid) complex.
Mohamed-Ahmed AH; Seifert K; Yardley V; Burrell-Saward H; Brocchini S; Croft SL
Antimicrob Agents Chemother; 2013 Oct; 57(10):4608-14. PubMed ID: 23796924
[TBL] [Abstract][Full Text] [Related]
3. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.
Zia Q; Khan AA; Swaleha Z; Owais M
Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804
[TBL] [Abstract][Full Text] [Related]
4. Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation.
Gupta PK; Jaiswal AK; Kumar V; Verma A; Dwivedi P; Dube A; Mishra PR
Mol Pharm; 2014 Mar; 11(3):951-63. PubMed ID: 24495144
[TBL] [Abstract][Full Text] [Related]
5. Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes.
Prajapati VK; Awasthi K; Gautam S; Yadav TP; Rai M; Srivastava ON; Sundar S
J Antimicrob Chemother; 2011 Apr; 66(4):874-9. PubMed ID: 21393222
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
Gangadhar KN; Adhikari K; Srichana T
Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
[TBL] [Abstract][Full Text] [Related]
7. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
[TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion.
Rochelle do Vale Morais A; Silva AL; Cojean S; Balaraman K; Bories C; Pomel S; Barratt G; do Egito EST; Loiseau PM
Exp Parasitol; 2018 Sep; 192():85-92. PubMed ID: 30075233
[TBL] [Abstract][Full Text] [Related]
9. N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents.
Nicoletti S; Seifert K; Gilbert IH
Int J Antimicrob Agents; 2009 May; 33(5):441-8. PubMed ID: 19097763
[TBL] [Abstract][Full Text] [Related]
10. Nanonization increases the antileishmanial efficacy of amphotericin B: an ex vivo approach.
Manandhar KD; Yadav TP; Prajapati VK; Basukala O; Aganja RP; Dude A; Shrivastav ON; Sundar S
Adv Exp Med Biol; 2014; 808():77-91. PubMed ID: 24595612
[TBL] [Abstract][Full Text] [Related]
11. In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum.
Ordóñez-Gutiérrez L; Espada-Fernández R; Dea-Ayuela MA; Torrado JJ; Bolás-Fernandez F; Alunda JM
Int J Antimicrob Agents; 2007 Oct; 30(4):325-9. PubMed ID: 17631982
[TBL] [Abstract][Full Text] [Related]
12. Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis.
Singh PK; Pawar VK; Jaiswal AK; Singh Y; Srikanth CH; Chaurasia M; Bora HK; Raval K; Meher JG; Gayen JR; Dube A; Chourasia MK
Int J Biol Macromol; 2017 Dec; 105(Pt 1):1220-1231. PubMed ID: 28780414
[TBL] [Abstract][Full Text] [Related]
13. Efficacious treatment of experimental leishmaniasis with amphotericin B-arabinogalactan water-soluble derivatives.
Golenser J; Frankenburg S; Ehrenfreund T; Domb AJ
Antimicrob Agents Chemother; 1999 Sep; 43(9):2209-14. PubMed ID: 10471566
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.
Jain V; Gupta A; Pawar VK; Asthana S; Jaiswal AK; Dube A; Chourasia MK
Appl Biochem Biotechnol; 2014 Oct; 174(4):1309-1330. PubMed ID: 25106894
[TBL] [Abstract][Full Text] [Related]
15. Exploitation of lectinized lipo-polymerosome encapsulated Amphotericin B to target macrophages for effective chemotherapy of visceral leishmaniasis.
Gupta PK; Asthana S; Jaiswal AK; Kumar V; Verma AK; Shukla P; Dwivedi P; Dube A; Mishra PR
Bioconjug Chem; 2014 Jun; 25(6):1091-102. PubMed ID: 24842628
[TBL] [Abstract][Full Text] [Related]
16. Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies.
Mudavath SL; Talat M; Rai M; Srivastava ON; Sundar S
Drug Des Devel Ther; 2014; 8():1235-47. PubMed ID: 25214767
[TBL] [Abstract][Full Text] [Related]
17. Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of amphotericin B: formulation development and in vitro and in vivo evaluation.
Jain K; Verma AK; Mishra PR; Jain NK
Antimicrob Agents Chemother; 2015 May; 59(5):2479-87. PubMed ID: 25645852
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and
Iman M; Huang Z; Alavizadeh SH; Szoka FC; Jaafari MR
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630182
[TBL] [Abstract][Full Text] [Related]
19. Nanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasis.
Caldeira LR; Fernandes FR; Costa DF; Frézard F; Afonso LC; Ferreira LA
Eur J Pharm Sci; 2015 Apr; 70():125-31. PubMed ID: 25660615
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a di-stigma-steryl-hemi-succinoyl-glycero-phosphocholine liposome-intercalated amphotericin B.
Iman M; Huang Z; Szoka FC; Jaafari MR
Int J Pharm; 2011 Apr; 408(1-2):163-72. PubMed ID: 21277963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
